Clinical Trial

Perioperative and Postoperative Evaluation of Rectal and Urogenital Function in Patients Undergoing Rectal Resection

Study acronym: PERIFUNC
Recruiting
View on ClinicalTrials.gov →
Summary
The aim of this study is the systematic analysis of the development of perioperative rectal and urogenital function in patients undergoing rectal resection with total mesorectal excision and the identification of risk factors for urogenital and sphincter function loss after this procedure. Knowledge of the corresponding risk factors could enable the identification of patient cohorts that could benefit from an intensified or altered postoperative treatment path. The results of this study could thus significantly influence the clinical management of patients with rectal cancer and improve the functional outcome in the long term.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2022-02-24; most recent amendment 2024-06-12.
Trial Details
NCT Number NCT05257746
Lead Sponsor Technische Universität Dresden
Conditions Rectal Surgery
Enrollment 500 participants
Start Date 2021-03-03
Primary Completion 2030-06-30 (estimated)
Study Completion 2030-06-30 (estimated)
Updated on ClinicalTrials.gov 2024-06-13